Overview

Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and effectiveness of peginterferon alfa-2a and ribavirin therapy in Korean chronic hepatitis C patients.
Phase:
Phase 4
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Gangnam Severance Hospital
Korea University Guro Hospital
Samsung Medical Center
Seoul St. Mary's Hospital
Severance Hospital
Treatments:
Interferon-alpha
Peginterferon alfa-2a
Ribavirin